title: The schizophrenic career of a "monster drug".
authors.forename: C L
authors.initials: CL
authors.lastname: Crawford
mesh_terms: D003622:Dapsone / Q000627:therapeutic use; D004893:Erythema Nodosum / Q000188:drug therapy*; D006801:Humans; D007917:Leprostatic Agents / Q000627:therapeutic use; D007918:Leprosy / Q000517:prevention & control; D015440:Leprosy, Lepromatous / Q000188:drug therapy*; D009422:Nervous System Diseases / Q000139:chemically induced*; D017511:Pyoderma Gangrenosum / Q000188:drug therapy; D013792:Thalidomide / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D007917:Leprostatic Agents; D013792:Thalidomide; D003622:Dapsone